Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -123.9 Million USD | 10.24% |
| 2022 | -138.04 Million USD | 30.37% |
| 2021 | -198.25 Million USD | -302.23% |
| 2020 | 98.03 Million USD | 36.82% |
| 2019 | 71.65 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -120.27 Million USD | 2.93% |
| 2024 Q2 | -114.91 Million USD | 4.46% |
| 2024 Q3 | -118.99 Million USD | -3.55% |
| 2023 Q2 | -126.1 Million USD | -1.14% |
| 2023 Q3 | -125.33 Million USD | 0.61% |
| 2023 Q4 | -123.9 Million USD | 1.14% |
| 2023 Q1 | -124.68 Million USD | 9.68% |
| 2023 FY | -123.9 Million USD | 10.24% |
| 2022 Q2 | -166.62 Million USD | 9.51% |
| 2022 FY | -138.04 Million USD | 30.37% |
| 2022 Q4 | -138.04 Million USD | 9.56% |
| 2022 Q3 | -152.63 Million USD | 8.39% |
| 2022 Q1 | -184.12 Million USD | 7.13% |
| 2021 FY | -198.25 Million USD | -302.23% |
| 2021 Q1 | -374.7 Thousand USD | 97.17% |
| 2021 Q2 | -248.17 Million USD | -66131.04% |
| 2021 Q3 | -222.86 Million USD | 10.2% |
| 2021 Q4 | -198.25 Million USD | 11.04% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 98.03 Million USD | 36.82% |
| 2020 Q4 | -13.24 Million USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 FY | 71.65 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 108.784% |
| Addus HomeCare Corporation | 110.39 Million USD | 212.245% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 238.59% |
| Amedisys, Inc. | 341.35 Million USD | 136.299% |
| American Oncology Network, Inc. | 99.78 Million USD | 224.174% |
| Astrana Health, Inc. | 27.2 Million USD | 555.427% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 108.515% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | -55837.628% |
| biote Corp. | 25.86 Million USD | 578.983% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 1281.205% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | -947.671% |
| COMPASS Pathways plc | -187.58 Million USD | 33.947% |
| DocGo Inc. | -12.78 Million USD | -868.864% |
| The Ensign Group, Inc. | 1.36 Billion USD | 109.1% |
| Healthcare Services Group, Inc. | -10.69 Million USD | -1058.56% |
| InnovAge Holding Corp. | 56.08 Million USD | 320.913% |
| Assure Holdings Corp. | 14.68 Million USD | 943.945% |
| The Joint Corp. | -2.47 Million USD | -4897.378% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 128.668% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | -1947.876% |
| ModivCare Inc. | 1.13 Billion USD | 110.895% |
| NewGenIvf Group Limited | 278.44 Thousand USD | 44599.352% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | 3155.439% |
| Option Care Health, Inc. | 822.56 Million USD | 115.064% |
| P3 Health Partners Inc. | 83.7 Million USD | 248.026% |
| P3 Health Partners Inc. | 83.7 Million USD | 248.026% |
| The Pennant Group, Inc. | 323.57 Million USD | 138.294% |
| Surgery Partners, Inc. | 2.86 Billion USD | 104.324% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | -3986.713% |
| Talkspace, Inc. | -123.9 Million USD | -0.0% |
| The Oncology Institute, Inc. | 86.32 Million USD | 243.533% |
| The Oncology Institute, Inc. | 86.32 Million USD | 243.533% |